
1. hematol oncol clin north am. 1987 dec;1(4):801-39.

management infections children cancer.

barson wj(1), brady mt.

author information: 
(1)ohio state university college medicine pharmacy, columbus.

infectious complications remain frequent cause morbidity mortality in
children cancer, especially granulocytopenic. physicians
caring children must approach new febrile episode were
life threatening. questions concerning present illness must comprehensive.
the physical examination done compulsive manner more
obvious signs inflammation often absent granulocytopenia.
immediate initiation broad-spectrum intravenous antibiotic coverage is
required appropriate specimens diagnostic microbiology studies 
been obtained. patients may exhibit either dramatic or, often,
only subtle clinical findings, must monitored closely complete
physical examination least daily. laboratory studies frequently determine 
the etiology fever. therapy modified, based upon the
particular pathogen isolated type infection identified. because
bacterial infections responsible infectious febrile episodes 
granulocytopenic child cancer, appropriate antibiotic therapy usually is
curative. however, patients remain febrile granulocytopenic without
explanation. patients frequently fungal infection respond to
amphotericin b therapy. present armamentarium antimicrobial agents against
the common pathogens encountered cancer patients, except cytomegalovirus, 
is adequate. future advances therapy infections children cancer
will probably area immunotherapy. would include passive
administration products strengthen debilitated immune system, together
with active immunization aim prevent infectious complications.
prevention infection cancer population may one keys to
producing longer remissions prolonged overall survival, enabling pediatric
oncologists administer intensive induction chemotherapy.


pmid: 3323184  [indexed medline]

